Loading...

PerCP/Cyanine5.5 anti-mouse CD45 Antibody PerCP/Cyanine5.5 anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_PerCPCyanine55_CD45_Antibody_082418
C57BL/6 mouse splenocytes were stained with CD45 (Clone 30-F11) PerCP/Cyanine5.5 (filled histogram), or rat IgG2b, κ PerCP/Cyanine5.5 isotype control (open histogram).
  • 30-F11_PerCPCyanine55_CD45_Antibody_082418
    C57BL/6 mouse splenocytes were stained with CD45 (Clone 30-F11) PerCP/Cyanine5.5 (filled histogram), or rat IgG2b, κ PerCP/Cyanine5.5 isotype control (open histogram).
Compare all formats See PerCP/Cyanine5.5 spectral data
Cat # Size Price Quantity Check Availability Save
103131 25 µg DKK517
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103132 100 µg DKK1313
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  2. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  3. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  4. Xuan W, et al. 2022. Cancer Immunol Res. 10:770. PubMed
  5. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  6. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  7. Wu X, et al. 2022. J Clin Med. 11: . PubMed
  8. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  9. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  10. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  11. Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed
  12. Lai C, et al. 2023. J Bone Miner Res. 38:86. PubMed
  13. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  14. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  15. Zha AH, et al. 2022. Lupus Sci Med. 9: . PubMed
  16. Guo J, et al. 2023. Cell Rep Med. 4:100881. PubMed
  17. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  18. Liu G, et al. 2023. Commun Biol. 6:102. PubMed
  19. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  20. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  21. Khan NZ, et al. 2021. Brain Behav Immun. 92:165. PubMed
  22. Na E, et al. 2022. Am J Physiol Lung Cell Mol Physiol. 322:L550. PubMed
  23. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  24. Li X, et al. 2022. Cell. 185:1709. PubMed
  25. Zhang Q, et al. 2022. Nat Metab. 4:1055. PubMed
  26. Bermea KC, et al. 2022. J Vis Exp. . PubMed
  27. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  28. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  29. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  30. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  31. Fei F, et al. 2022. Int J Mol Sci. 23:. PubMed
  32. Shi H, et al. 2022. Nutrients. 14:. PubMed
  33. Li J, et al. 2022. Elife. 11:. PubMed
  34. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  35. Xiao Y, et al. 2023. EMBO J. 42:e111762. PubMed
  36. He Y, et al. 2023. Biomolecules. 13:. PubMed
  37. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  38. Doloff JC, et al. 2023. Sci Adv. 9:eade9488. PubMed
  39. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  40. Xiong W, et al. 2022. Nat Commun. 13:1700. PubMed
  41. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  42. Jung IY, et al. 2022. Sci Transl Med. 14:eabn7336. PubMed
  43. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  44. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
  45. Daemen S, et al. 2021. Cell Reports. 34(2):108626. PubMed
  46. Zaman R, et al. 2021. Immunity. :. PubMed
  47. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  48. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  49. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  50. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  51. Padonou F, et al. 2022. EMBO Rep. 23:e53576. PubMed
  52. Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed
  53. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  54. Li Y, et al. 2022. Int J Biol Sci. 18:3697. PubMed
  55. Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed
  56. Li Z, et al. 2021. Immunology. 163:105. PubMed
  57. Krausgruber T, et al. 2020. Nature. 583:296. PubMed
  58. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  59. Rodda LB et al. 2018. Immunity. 48(5):1014-1028 . PubMed
  60. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  61. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  62. Yang M, et al. 2020. Cell Prolif. 53:e12784. PubMed
  63. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  64. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  65. Browning D, et al. 2017. Gene Ther. 10.1038/gt.2016.88. PubMed
  66. Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed
  67. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  68. Garcia–Agudo LF, et al. 2019. FASEB J. :fj201900337R. PubMed
  69. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  70. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  71. Biffi G, et al. 2018. Cancer Discov. 2:282. PubMed
  72. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  73. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  74. Craver BM, et al. 2020. Blood Adv. 4:312. PubMed
  75. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
  76. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  77. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  78. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  79. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  80. Potluri HK, et al. 2022. J Immunother Cancer. 10:. PubMed
  81. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  82. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  83. Fernandez Garcia-Agudo L, et al. 2021. Cell Rep. 36:109548. PubMed
  84. Chung H, et al. 2021. Immune Netw. 21:e28. PubMed
  85. Shen H, et al. 2022. Nat Commun. 13:6030. PubMed
  86. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  87. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  88. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  89. Damal Villivalam S, et al. 2020. Nat Commun. 4313:11. PubMed
  90. Sakaguchi M, et al. 2022. Nat Commun. 13:6092. PubMed
  91. Chimenti I, et al. 2022. Cell Death Discov. 8:149. PubMed
  92. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  93. Wang C, et al. 2021. Cell Stem Cell. . PubMed
  94. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  95. Vasilijevic J, et al. 2017. PLoS Pathog. 13:e1006650. PubMed
  96. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  97. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  98. Alexander RK, et al. 2020. eLife. 9:e54090.. PubMed
  99. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  100. Peres-Emidio EC, et al. 2022. Front Cell Infect Microbiol. 12:811474. PubMed
  101. Cong M, et al. 2021. Methods Mol Biol. 2388:59. PubMed
  102. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  103. Fleury M, et al. 2015. Development. 142: 3307 - 3320. PubMed
  104. Osborne JK, et al. 2021. Cell Reports. 36(3):109408. PubMed
  105. Wei SC, et al. 2020. Cancer Discov. . PubMed
  106. Voisin M, et al. 2021. Commun Biol. 4:420. PubMed
  107. Nicholas DA, et al. 2020. Scientific Reports. 10(1):13063. PubMed
  108. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  109. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  110. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  111. Lee J, et al. 2022. Nat Commun. 13:1516. PubMed
  112. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  113. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  114. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  115. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  116. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  117. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  118. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  119. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  120. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  121. Li N, et al. 2021. eLife. 10:00. PubMed
  122. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  123. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  124. Adrover JM et al. 2019. Immunity. 50(2):390-402 . PubMed
  125. Christ A, et al. 2018. Cell. 172:162. PubMed
  126. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  127. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  128. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  129. Yang Z, et al. 2021. Sci Adv. 7:. PubMed
  130. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  131. Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed
  132. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  133. Hu Y, et al. 2021. Bioact Mater. 2905:6. PubMed
  134. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  135. Hsu CY, et al. 2020. Frontiers in Immunology. 11:574839. PubMed
  136. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  137. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  138. Du Q et al. 2019. Dev Cell. 49(4):618-631 . PubMed
  139. Branchett WJ, et al. 2020. Wellcome Open Research. 0.278472222. PubMed
  140. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  141. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  142. Mittal A, et al. 2021. Sci Rep. 11:10731. PubMed
  143. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  144. Liu Z, et al. 2015. Development. 142: 2452 - 2463. PubMed
  145. Wang Y, et al. 2020. Cell Death Dis. 1.169444444. PubMed
  146. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  147. Shao M, et al. 2021. Cell Stem Cell. 28(4):685-701.e7. PubMed
  148. Timblin GA, et al. 2021. Nat Metab. 3:618. PubMed
  149. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  150. Lang V, et al. 2021. Elife. 10:. PubMed
  151. Toth K, et al. 2022. PLoS Biol. 20:e3001526. PubMed
  152. Weinstock A, et al. 2021. Elife. :10. PubMed
  153. Joffin N, et al. 2021. Cell Stem Cell. 28(4):702-717.e8. PubMed
  154. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  155. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  156. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  157. Sun L, et al. 2015. Sci Rep. 5: 14871. PubMed
  158. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  159. Li CJ, et al. 2018. J Clin Invest. 128:5251. PubMed
  160. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  161. Tuong ZK, et al. 2021. iScience. 24:103326. PubMed
  162. Thomas K, et al. 2022. JCI Insight. :. PubMed
  163. Xu X, et al. 2022. EMBO Rep. 23:e53509. PubMed
  164. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  165. Chandra J, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.83. PubMed
  166. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  167. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  168. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  169. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  170. Ngamsri KC, et al. 2020. Front Immunol. 11:407. PubMed
  171. Haider N, et al. 2020. Cell Commun Signal. 18:26. PubMed
  172. Bernstock JD, et al. 2019. J Allergy Clin Immunol. 145:358. PubMed
  173. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  174. Calle P, et al. 2021. Cells. 10:. PubMed
  175. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  176. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  177. Dong X, et al. 2022. Front Immunol. 13:896472. PubMed
  178. Pizzurro GA, et al. 2021. Cancers (Basel). 13:. PubMed
  179. Olson B, et al. 2021. Brain Behav Immun. 97:102. PubMed
  180. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  181. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  182. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  183. Klose A, et al. 2018. JCSM Rapid Commun. 9:20222. PubMed
  184. Casanova-Acebes M, et al. 2018. J Exp Med. 215:2778. PubMed
  185. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  186. Scott NA, et al. 2018. Front Immunol. 2.319444444. PubMed
  187. Karolin A, et al. 2022. Front Pharmacol. 12:789080. PubMed
  188. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  189. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  190. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
  191. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  192. Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed
  193. Ko HJ, et al. 2020. Front Immunol. 1897:11. PubMed
  194. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  195. Böhm AM et al. 2019. Dev Cell. 51(2):236-254 . PubMed
  196. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  197. Mello AM, et al. 2022. Oncogenesis. 11:56. PubMed
  198. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  199. Sánchez-del-Campo L, et al. 2021. J Exp Clin Cancer Res. 40:117. PubMed
  200. Steele NG, et al. 2021. Clin Cancer Res. 27:2023. PubMed
  201. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  202. Mesnieres M, et al. 2021. Cell Reports. 36(8):109618. PubMed
  203. Doss PMIA, et al. 2021. Cell Reports. 34(10):108833. PubMed
  204. Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed
  205. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  206. Baron CS, et al. 2018. Nat Commun. 9:2517. PubMed
  207. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  208. Miragaia RJ, et al. 2018. Sci Rep. 8:685. PubMed
  209. Yu H, et al. 2021. Cell Death Dis. 13:1. PubMed
  210. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  211. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  212. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  213. Patel K, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.11. PubMed
  214. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  215. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  216. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  217. Chung S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. L921:318. PubMed
  218. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  219. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  220. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  221. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  222. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  223. Schulze J, et al. 2021. Stroke. 52:2939. PubMed
  224. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  225. Liu SS, et al. 2021. Immunity. :. PubMed
  226. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  227. Gao P, et al. 2020. Front Immunol. 1.636111111. PubMed
  228. Durga Devi T, et al. 2017. Am J Pathol. 187:2659. PubMed
  229. Wang L, et al. 2020. Nat Commun. 0.654166667. PubMed
  230. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  231. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  232. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  233. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  234. Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed
  235. Garcia-Alegria E, et al. 2016. Sci Rep. 6: 25917. PubMed
  236. Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed
  237. Mitchell LA, et al. 2019. Oncotarget. 10:2252. PubMed
  238. Han Y, et al. 2019. J Clin Invest. 130:26. PubMed
  239. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  240. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  241. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  242. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  243. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
  244. Sheriff L, et al. 2020. Dis Model Mech. 13:dmm046383. PubMed
  245. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
  246. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  247. Omori S, et al. 2020. Cell Metabolism. 32(5):814-828.e6. PubMed
  248. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  249. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  250. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  251. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  252. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  253. Xuan W, et al. 2022. Cancer Immunol Res. 10:770. PubMed
  254. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  255. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  256. Wu X, et al. 2022. J Clin Med. 11: . PubMed
  257. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  258. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  259. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  260. Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed
  261. Lai C, et al. 2023. J Bone Miner Res. 38:86. PubMed
  262. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  263. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  264. Zha AH, et al. 2022. Lupus Sci Med. 9: . PubMed
  265. Guo J, et al. 2023. Cell Rep Med. 4:100881. PubMed
  266. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  267. Liu G, et al. 2023. Commun Biol. 6:102. PubMed
  268. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  269. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  270. Khan NZ, et al. 2021. Brain Behav Immun. 92:165. PubMed
  271. Na E, et al. 2022. Am J Physiol Lung Cell Mol Physiol. 322:L550. PubMed
  272. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  273. Li X, et al. 2022. Cell. 185:1709. PubMed
  274. Zhang Q, et al. 2022. Nat Metab. 4:1055. PubMed
  275. Bermea KC, et al. 2022. J Vis Exp. . PubMed
  276. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  277. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  278. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  279. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  280. Fei F, et al. 2022. Int J Mol Sci. 23:. PubMed
  281. Shi H, et al. 2022. Nutrients. 14:. PubMed
  282. Li J, et al. 2022. Elife. 11:. PubMed
  283. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  284. Xiao Y, et al. 2023. EMBO J. 42:e111762. PubMed
  285. He Y, et al. 2023. Biomolecules. 13:. PubMed
  286. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  287. Doloff JC, et al. 2023. Sci Adv. 9:eade9488. PubMed
  288. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  289. Xiong W, et al. 2022. Nat Commun. 13:1700. PubMed
  290. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  291. Jung IY, et al. 2022. Sci Transl Med. 14:eabn7336. PubMed
  292. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  293. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
  294. Daemen S, et al. 2021. Cell Reports. 34(2):108626. PubMed
  295. Zaman R, et al. 2021. Immunity. :. PubMed
  296. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  297. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  298. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  299. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  300. Padonou F, et al. 2022. EMBO Rep. 23:e53576. PubMed
  301. Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed
  302. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  303. Li Y, et al. 2022. Int J Biol Sci. 18:3697. PubMed
  304. Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed
  305. Li Z, et al. 2021. Immunology. 163:105. PubMed
  306. Krausgruber T, et al. 2020. Nature. 583:296. PubMed
  307. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  308. Rodda LB et al. 2018. Immunity. 48(5):1014-1028 . PubMed
  309. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  310. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  311. Yang M, et al. 2020. Cell Prolif. 53:e12784. PubMed
  312. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  313. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  314. Browning D, et al. 2017. Gene Ther. 10.1038/gt.2016.88. PubMed
  315. Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed
  316. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  317. Garcia–Agudo LF, et al. 2019. FASEB J. :fj201900337R. PubMed
  318. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  319. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  320. Biffi G, et al. 2018. Cancer Discov. 2:282. PubMed
  321. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  322. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  323. Craver BM, et al. 2020. Blood Adv. 4:312. PubMed
  324. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
  325. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  326. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  327. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  328. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  329. Potluri HK, et al. 2022. J Immunother Cancer. 10:. PubMed
  330. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  331. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  332. Fernandez Garcia-Agudo L, et al. 2021. Cell Rep. 36:109548. PubMed
  333. Chung H, et al. 2021. Immune Netw. 21:e28. PubMed
  334. Shen H, et al. 2022. Nat Commun. 13:6030. PubMed
  335. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  336. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  337. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  338. Damal Villivalam S, et al. 2020. Nat Commun. 4313:11. PubMed
  339. Sakaguchi M, et al. 2022. Nat Commun. 13:6092. PubMed
  340. Chimenti I, et al. 2022. Cell Death Discov. 8:149. PubMed
  341. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  342. Wang C, et al. 2021. Cell Stem Cell. . PubMed
  343. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  344. Vasilijevic J, et al. 2017. PLoS Pathog. 13:e1006650. PubMed
  345. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  346. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  347. Alexander RK, et al. 2020. eLife. 9:e54090.. PubMed
  348. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  349. Peres-Emidio EC, et al. 2022. Front Cell Infect Microbiol. 12:811474. PubMed
  350. Cong M, et al. 2021. Methods Mol Biol. 2388:59. PubMed
  351. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  352. Fleury M, et al. 2015. Development. 142: 3307 - 3320. PubMed
  353. Osborne JK, et al. 2021. Cell Reports. 36(3):109408. PubMed
  354. Wei SC, et al. 2020. Cancer Discov. . PubMed
  355. Voisin M, et al. 2021. Commun Biol. 4:420. PubMed
  356. Nicholas DA, et al. 2020. Scientific Reports. 10(1):13063. PubMed
  357. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  358. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  359. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  360. Lee J, et al. 2022. Nat Commun. 13:1516. PubMed
  361. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  362. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  363. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  364. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  365. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  366. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  367. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  368. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  369. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  370. Li N, et al. 2021. eLife. 10:00. PubMed
  371. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  372. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  373. Adrover JM et al. 2019. Immunity. 50(2):390-402 . PubMed
  374. Christ A, et al. 2018. Cell. 172:162. PubMed
  375. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  376. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  377. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  378. Yang Z, et al. 2021. Sci Adv. 7:. PubMed
  379. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  380. Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed
  381. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  382. Hu Y, et al. 2021. Bioact Mater. 2905:6. PubMed
  383. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  384. Hsu CY, et al. 2020. Frontiers in Immunology. 11:574839. PubMed
  385. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  386. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  387. Du Q et al. 2019. Dev Cell. 49(4):618-631 . PubMed
  388. Branchett WJ, et al. 2020. Wellcome Open Research. 0.278472222. PubMed
  389. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  390. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  391. Mittal A, et al. 2021. Sci Rep. 11:10731. PubMed
  392. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  393. Liu Z, et al. 2015. Development. 142: 2452 - 2463. PubMed
  394. Wang Y, et al. 2020. Cell Death Dis. 1.169444444. PubMed
  395. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  396. Shao M, et al. 2021. Cell Stem Cell. 28(4):685-701.e7. PubMed
  397. Timblin GA, et al. 2021. Nat Metab. 3:618. PubMed
  398. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  399. Lang V, et al. 2021. Elife. 10:. PubMed
  400. Toth K, et al. 2022. PLoS Biol. 20:e3001526. PubMed
  401. Weinstock A, et al. 2021. Elife. :10. PubMed
  402. Joffin N, et al. 2021. Cell Stem Cell. 28(4):702-717.e8. PubMed
  403. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  404. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  405. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  406. Sun L, et al. 2015. Sci Rep. 5: 14871. PubMed
  407. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  408. Li CJ, et al. 2018. J Clin Invest. 128:5251. PubMed
  409. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  410. Tuong ZK, et al. 2021. iScience. 24:103326. PubMed
  411. Thomas K, et al. 2022. JCI Insight. :. PubMed
  412. Xu X, et al. 2022. EMBO Rep. 23:e53509. PubMed
  413. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  414. Chandra J, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.83. PubMed
  415. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  416. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  417. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  418. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  419. Ngamsri KC, et al. 2020. Front Immunol. 11:407. PubMed
  420. Haider N, et al. 2020. Cell Commun Signal. 18:26. PubMed
  421. Bernstock JD, et al. 2019. J Allergy Clin Immunol. 145:358. PubMed
  422. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  423. Calle P, et al. 2021. Cells. 10:. PubMed
  424. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  425. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  426. Dong X, et al. 2022. Front Immunol. 13:896472. PubMed
  427. Pizzurro GA, et al. 2021. Cancers (Basel). 13:. PubMed
  428. Olson B, et al. 2021. Brain Behav Immun. 97:102. PubMed
  429. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  430. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  431. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  432. Klose A, et al. 2018. JCSM Rapid Commun. 9:20222. PubMed
  433. Casanova-Acebes M, et al. 2018. J Exp Med. 215:2778. PubMed
  434. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  435. Scott NA, et al. 2018. Front Immunol. 2.319444444. PubMed
  436. Karolin A, et al. 2022. Front Pharmacol. 12:789080. PubMed
  437. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  438. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  439. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
  440. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  441. Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed
  442. Ko HJ, et al. 2020. Front Immunol. 1897:11. PubMed
  443. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  444. Böhm AM et al. 2019. Dev Cell. 51(2):236-254 . PubMed
  445. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  446. Mello AM, et al. 2022. Oncogenesis. 11:56. PubMed
  447. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  448. Sánchez-del-Campo L, et al. 2021. J Exp Clin Cancer Res. 40:117. PubMed
  449. Steele NG, et al. 2021. Clin Cancer Res. 27:2023. PubMed
  450. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  451. Mesnieres M, et al. 2021. Cell Reports. 36(8):109618. PubMed
  452. Doss PMIA, et al. 2021. Cell Reports. 34(10):108833. PubMed
  453. Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed
  454. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  455. Baron CS, et al. 2018. Nat Commun. 9:2517. PubMed
  456. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  457. Miragaia RJ, et al. 2018. Sci Rep. 8:685. PubMed
  458. Yu H, et al. 2021. Cell Death Dis. 13:1. PubMed
  459. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  460. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  461. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  462. Patel K, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.11. PubMed
  463. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  464. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  465. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  466. Chung S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. L921:318. PubMed
  467. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  468. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  469. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  470. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  471. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  472. Schulze J, et al. 2021. Stroke. 52:2939. PubMed
  473. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  474. Liu SS, et al. 2021. Immunity. :. PubMed
  475. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  476. Gao P, et al. 2020. Front Immunol. 1.636111111. PubMed
  477. Durga Devi T, et al. 2017. Am J Pathol. 187:2659. PubMed
  478. Wang L, et al. 2020. Nat Commun. 0.654166667. PubMed
  479. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  480. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  481. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  482. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  483. Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed
  484. Garcia-Alegria E, et al. 2016. Sci Rep. 6: 25917. PubMed
  485. Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed
  486. Mitchell LA, et al. 2019. Oncotarget. 10:2252. PubMed
  487. Han Y, et al. 2019. J Clin Invest. 130:26. PubMed
  488. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  489. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  490. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  491. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  492. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
  493. Sheriff L, et al. 2020. Dis Model Mech. 13:dmm046383. PubMed
  494. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
  495. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  496. Omori S, et al. 2020. Cell Metabolism. 32(5):814-828.e6. PubMed
  497. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  498. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
RRID
AB_893344 (BioLegend Cat. No. 103131)
AB_893340 (BioLegend Cat. No. 103132)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

How stable is PerCP/Cyanine5.5 tandem as compared to PerCP alone?

PerCP/Cyanine5.5 is quite photostable and also better than PerCP alone in withstanding fixation.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC
StarBright UltraViolet 740 anti-mouse CD45 30-F11 FC
Go To Top Version: 3    Revision Date: 08/24/2018

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_PerCPCyanine55_CD45_Antibody_082418
C57BL/6 mouse splenocytes were stained with CD45 (Clone 30-F11) PerCP/Cyanine5.5 (filled histogram), or rat IgG2b, κ PerCP/Cyanine5.5 isotype control (open histogram).
  • 30-F11_PerCPCyanine55_CD45_Antibody_082418
    C57BL/6 mouse splenocytes were stained with CD45 (Clone 30-F11) PerCP/Cyanine5.5 (filled histogram), or rat IgG2b, κ PerCP/Cyanine5.5 isotype control (open histogram).
Compare all formats See PerCP/Cyanine5.5 spectral data
Cat # Size Price Quantity Check Availability Save
103131 25 µg DKK517
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103132 100 µg DKK1313
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  2. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  3. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  4. Xuan W, et al. 2022. Cancer Immunol Res. 10:770. PubMed
  5. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  6. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  7. Wu X, et al. 2022. J Clin Med. 11: . PubMed
  8. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  9. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  10. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  11. Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed
  12. Lai C, et al. 2023. J Bone Miner Res. 38:86. PubMed
  13. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  14. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  15. Zha AH, et al. 2022. Lupus Sci Med. 9: . PubMed
  16. Guo J, et al. 2023. Cell Rep Med. 4:100881. PubMed
  17. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  18. Liu G, et al. 2023. Commun Biol. 6:102. PubMed
  19. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  20. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  21. Khan NZ, et al. 2021. Brain Behav Immun. 92:165. PubMed
  22. Na E, et al. 2022. Am J Physiol Lung Cell Mol Physiol. 322:L550. PubMed
  23. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  24. Li X, et al. 2022. Cell. 185:1709. PubMed
  25. Zhang Q, et al. 2022. Nat Metab. 4:1055. PubMed
  26. Bermea KC, et al. 2022. J Vis Exp. . PubMed
  27. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  28. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  29. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  30. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  31. Fei F, et al. 2022. Int J Mol Sci. 23:. PubMed
  32. Shi H, et al. 2022. Nutrients. 14:. PubMed
  33. Li J, et al. 2022. Elife. 11:. PubMed
  34. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  35. Xiao Y, et al. 2023. EMBO J. 42:e111762. PubMed
  36. He Y, et al. 2023. Biomolecules. 13:. PubMed
  37. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  38. Doloff JC, et al. 2023. Sci Adv. 9:eade9488. PubMed
  39. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  40. Xiong W, et al. 2022. Nat Commun. 13:1700. PubMed
  41. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  42. Jung IY, et al. 2022. Sci Transl Med. 14:eabn7336. PubMed
  43. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  44. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
  45. Daemen S, et al. 2021. Cell Reports. 34(2):108626. PubMed
  46. Zaman R, et al. 2021. Immunity. :. PubMed
  47. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  48. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  49. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  50. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  51. Padonou F, et al. 2022. EMBO Rep. 23:e53576. PubMed
  52. Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed
  53. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  54. Li Y, et al. 2022. Int J Biol Sci. 18:3697. PubMed
  55. Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed
  56. Li Z, et al. 2021. Immunology. 163:105. PubMed
  57. Krausgruber T, et al. 2020. Nature. 583:296. PubMed
  58. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  59. Rodda LB et al. 2018. Immunity. 48(5):1014-1028 . PubMed
  60. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  61. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  62. Yang M, et al. 2020. Cell Prolif. 53:e12784. PubMed
  63. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  64. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  65. Browning D, et al. 2017. Gene Ther. 10.1038/gt.2016.88. PubMed
  66. Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed
  67. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  68. Garcia–Agudo LF, et al. 2019. FASEB J. :fj201900337R. PubMed
  69. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  70. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  71. Biffi G, et al. 2018. Cancer Discov. 2:282. PubMed
  72. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  73. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  74. Craver BM, et al. 2020. Blood Adv. 4:312. PubMed
  75. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
  76. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  77. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  78. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  79. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  80. Potluri HK, et al. 2022. J Immunother Cancer. 10:. PubMed
  81. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  82. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  83. Fernandez Garcia-Agudo L, et al. 2021. Cell Rep. 36:109548. PubMed
  84. Chung H, et al. 2021. Immune Netw. 21:e28. PubMed
  85. Shen H, et al. 2022. Nat Commun. 13:6030. PubMed
  86. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  87. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  88. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  89. Damal Villivalam S, et al. 2020. Nat Commun. 4313:11. PubMed
  90. Sakaguchi M, et al. 2022. Nat Commun. 13:6092. PubMed
  91. Chimenti I, et al. 2022. Cell Death Discov. 8:149. PubMed
  92. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  93. Wang C, et al. 2021. Cell Stem Cell. . PubMed
  94. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  95. Vasilijevic J, et al. 2017. PLoS Pathog. 13:e1006650. PubMed
  96. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  97. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  98. Alexander RK, et al. 2020. eLife. 9:e54090.. PubMed
  99. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  100. Peres-Emidio EC, et al. 2022. Front Cell Infect Microbiol. 12:811474. PubMed
  101. Cong M, et al. 2021. Methods Mol Biol. 2388:59. PubMed
  102. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  103. Fleury M, et al. 2015. Development. 142: 3307 - 3320. PubMed
  104. Osborne JK, et al. 2021. Cell Reports. 36(3):109408. PubMed
  105. Wei SC, et al. 2020. Cancer Discov. . PubMed
  106. Voisin M, et al. 2021. Commun Biol. 4:420. PubMed
  107. Nicholas DA, et al. 2020. Scientific Reports. 10(1):13063. PubMed
  108. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  109. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  110. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  111. Lee J, et al. 2022. Nat Commun. 13:1516. PubMed
  112. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  113. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  114. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  115. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  116. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  117. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  118. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  119. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  120. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  121. Li N, et al. 2021. eLife. 10:00. PubMed
  122. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  123. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  124. Adrover JM et al. 2019. Immunity. 50(2):390-402 . PubMed
  125. Christ A, et al. 2018. Cell. 172:162. PubMed
  126. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  127. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  128. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  129. Yang Z, et al. 2021. Sci Adv. 7:. PubMed
  130. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  131. Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed
  132. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  133. Hu Y, et al. 2021. Bioact Mater. 2905:6. PubMed
  134. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  135. Hsu CY, et al. 2020. Frontiers in Immunology. 11:574839. PubMed
  136. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  137. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  138. Du Q et al. 2019. Dev Cell. 49(4):618-631 . PubMed
  139. Branchett WJ, et al. 2020. Wellcome Open Research. 0.278472222. PubMed
  140. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  141. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  142. Mittal A, et al. 2021. Sci Rep. 11:10731. PubMed
  143. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  144. Liu Z, et al. 2015. Development. 142: 2452 - 2463. PubMed
  145. Wang Y, et al. 2020. Cell Death Dis. 1.169444444. PubMed
  146. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  147. Shao M, et al. 2021. Cell Stem Cell. 28(4):685-701.e7. PubMed
  148. Timblin GA, et al. 2021. Nat Metab. 3:618. PubMed
  149. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  150. Lang V, et al. 2021. Elife. 10:. PubMed
  151. Toth K, et al. 2022. PLoS Biol. 20:e3001526. PubMed
  152. Weinstock A, et al. 2021. Elife. :10. PubMed
  153. Joffin N, et al. 2021. Cell Stem Cell. 28(4):702-717.e8. PubMed
  154. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  155. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  156. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  157. Sun L, et al. 2015. Sci Rep. 5: 14871. PubMed
  158. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  159. Li CJ, et al. 2018. J Clin Invest. 128:5251. PubMed
  160. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  161. Tuong ZK, et al. 2021. iScience. 24:103326. PubMed
  162. Thomas K, et al. 2022. JCI Insight. :. PubMed
  163. Xu X, et al. 2022. EMBO Rep. 23:e53509. PubMed
  164. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  165. Chandra J, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.83. PubMed
  166. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  167. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  168. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  169. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  170. Ngamsri KC, et al. 2020. Front Immunol. 11:407. PubMed
  171. Haider N, et al. 2020. Cell Commun Signal. 18:26. PubMed
  172. Bernstock JD, et al. 2019. J Allergy Clin Immunol. 145:358. PubMed
  173. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  174. Calle P, et al. 2021. Cells. 10:. PubMed
  175. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  176. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  177. Dong X, et al. 2022. Front Immunol. 13:896472. PubMed
  178. Pizzurro GA, et al. 2021. Cancers (Basel). 13:. PubMed
  179. Olson B, et al. 2021. Brain Behav Immun. 97:102. PubMed
  180. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  181. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  182. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  183. Klose A, et al. 2018. JCSM Rapid Commun. 9:20222. PubMed
  184. Casanova-Acebes M, et al. 2018. J Exp Med. 215:2778. PubMed
  185. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  186. Scott NA, et al. 2018. Front Immunol. 2.319444444. PubMed
  187. Karolin A, et al. 2022. Front Pharmacol. 12:789080. PubMed
  188. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  189. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  190. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
  191. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  192. Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed
  193. Ko HJ, et al. 2020. Front Immunol. 1897:11. PubMed
  194. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  195. Böhm AM et al. 2019. Dev Cell. 51(2):236-254 . PubMed
  196. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  197. Mello AM, et al. 2022. Oncogenesis. 11:56. PubMed
  198. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  199. Sánchez-del-Campo L, et al. 2021. J Exp Clin Cancer Res. 40:117. PubMed
  200. Steele NG, et al. 2021. Clin Cancer Res. 27:2023. PubMed
  201. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  202. Mesnieres M, et al. 2021. Cell Reports. 36(8):109618. PubMed
  203. Doss PMIA, et al. 2021. Cell Reports. 34(10):108833. PubMed
  204. Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed
  205. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  206. Baron CS, et al. 2018. Nat Commun. 9:2517. PubMed
  207. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  208. Miragaia RJ, et al. 2018. Sci Rep. 8:685. PubMed
  209. Yu H, et al. 2021. Cell Death Dis. 13:1. PubMed
  210. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  211. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  212. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  213. Patel K, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.11. PubMed
  214. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  215. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  216. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  217. Chung S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. L921:318. PubMed
  218. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  219. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  220. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  221. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  222. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  223. Schulze J, et al. 2021. Stroke. 52:2939. PubMed
  224. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  225. Liu SS, et al. 2021. Immunity. :. PubMed
  226. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  227. Gao P, et al. 2020. Front Immunol. 1.636111111. PubMed
  228. Durga Devi T, et al. 2017. Am J Pathol. 187:2659. PubMed
  229. Wang L, et al. 2020. Nat Commun. 0.654166667. PubMed
  230. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  231. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  232. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  233. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  234. Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed
  235. Garcia-Alegria E, et al. 2016. Sci Rep. 6: 25917. PubMed
  236. Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed
  237. Mitchell LA, et al. 2019. Oncotarget. 10:2252. PubMed
  238. Han Y, et al. 2019. J Clin Invest. 130:26. PubMed
  239. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  240. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  241. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  242. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  243. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
  244. Sheriff L, et al. 2020. Dis Model Mech. 13:dmm046383. PubMed
  245. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
  246. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  247. Omori S, et al. 2020. Cell Metabolism. 32(5):814-828.e6. PubMed
  248. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  249. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  250. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  251. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  252. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  253. Xuan W, et al. 2022. Cancer Immunol Res. 10:770. PubMed
  254. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  255. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  256. Wu X, et al. 2022. J Clin Med. 11: . PubMed
  257. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  258. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  259. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  260. Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed
  261. Lai C, et al. 2023. J Bone Miner Res. 38:86. PubMed
  262. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  263. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  264. Zha AH, et al. 2022. Lupus Sci Med. 9: . PubMed
  265. Guo J, et al. 2023. Cell Rep Med. 4:100881. PubMed
  266. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  267. Liu G, et al. 2023. Commun Biol. 6:102. PubMed
  268. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  269. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  270. Khan NZ, et al. 2021. Brain Behav Immun. 92:165. PubMed
  271. Na E, et al. 2022. Am J Physiol Lung Cell Mol Physiol. 322:L550. PubMed
  272. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  273. Li X, et al. 2022. Cell. 185:1709. PubMed
  274. Zhang Q, et al. 2022. Nat Metab. 4:1055. PubMed
  275. Bermea KC, et al. 2022. J Vis Exp. . PubMed
  276. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  277. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  278. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  279. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  280. Fei F, et al. 2022. Int J Mol Sci. 23:. PubMed
  281. Shi H, et al. 2022. Nutrients. 14:. PubMed
  282. Li J, et al. 2022. Elife. 11:. PubMed
  283. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  284. Xiao Y, et al. 2023. EMBO J. 42:e111762. PubMed
  285. He Y, et al. 2023. Biomolecules. 13:. PubMed
  286. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  287. Doloff JC, et al. 2023. Sci Adv. 9:eade9488. PubMed
  288. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  289. Xiong W, et al. 2022. Nat Commun. 13:1700. PubMed
  290. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  291. Jung IY, et al. 2022. Sci Transl Med. 14:eabn7336. PubMed
  292. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  293. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
  294. Daemen S, et al. 2021. Cell Reports. 34(2):108626. PubMed
  295. Zaman R, et al. 2021. Immunity. :. PubMed
  296. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  297. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  298. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  299. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  300. Padonou F, et al. 2022. EMBO Rep. 23:e53576. PubMed
  301. Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed
  302. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  303. Li Y, et al. 2022. Int J Biol Sci. 18:3697. PubMed
  304. Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed
  305. Li Z, et al. 2021. Immunology. 163:105. PubMed
  306. Krausgruber T, et al. 2020. Nature. 583:296. PubMed
  307. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  308. Rodda LB et al. 2018. Immunity. 48(5):1014-1028 . PubMed
  309. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  310. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  311. Yang M, et al. 2020. Cell Prolif. 53:e12784. PubMed
  312. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  313. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  314. Browning D, et al. 2017. Gene Ther. 10.1038/gt.2016.88. PubMed
  315. Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed
  316. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  317. Garcia–Agudo LF, et al. 2019. FASEB J. :fj201900337R. PubMed
  318. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  319. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  320. Biffi G, et al. 2018. Cancer Discov. 2:282. PubMed
  321. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  322. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  323. Craver BM, et al. 2020. Blood Adv. 4:312. PubMed
  324. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
  325. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  326. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  327. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  328. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  329. Potluri HK, et al. 2022. J Immunother Cancer. 10:. PubMed
  330. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  331. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  332. Fernandez Garcia-Agudo L, et al. 2021. Cell Rep. 36:109548. PubMed
  333. Chung H, et al. 2021. Immune Netw. 21:e28. PubMed
  334. Shen H, et al. 2022. Nat Commun. 13:6030. PubMed
  335. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  336. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  337. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  338. Damal Villivalam S, et al. 2020. Nat Commun. 4313:11. PubMed
  339. Sakaguchi M, et al. 2022. Nat Commun. 13:6092. PubMed
  340. Chimenti I, et al. 2022. Cell Death Discov. 8:149. PubMed
  341. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  342. Wang C, et al. 2021. Cell Stem Cell. . PubMed
  343. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  344. Vasilijevic J, et al. 2017. PLoS Pathog. 13:e1006650. PubMed
  345. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  346. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  347. Alexander RK, et al. 2020. eLife. 9:e54090.. PubMed
  348. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  349. Peres-Emidio EC, et al. 2022. Front Cell Infect Microbiol. 12:811474. PubMed
  350. Cong M, et al. 2021. Methods Mol Biol. 2388:59. PubMed
  351. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  352. Fleury M, et al. 2015. Development. 142: 3307 - 3320. PubMed
  353. Osborne JK, et al. 2021. Cell Reports. 36(3):109408. PubMed
  354. Wei SC, et al. 2020. Cancer Discov. . PubMed
  355. Voisin M, et al. 2021. Commun Biol. 4:420. PubMed
  356. Nicholas DA, et al. 2020. Scientific Reports. 10(1):13063. PubMed
  357. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  358. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  359. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  360. Lee J, et al. 2022. Nat Commun. 13:1516. PubMed
  361. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  362. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  363. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  364. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  365. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  366. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  367. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  368. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  369. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  370. Li N, et al. 2021. eLife. 10:00. PubMed
  371. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  372. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  373. Adrover JM et al. 2019. Immunity. 50(2):390-402 . PubMed
  374. Christ A, et al. 2018. Cell. 172:162. PubMed
  375. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  376. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  377. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  378. Yang Z, et al. 2021. Sci Adv. 7:. PubMed
  379. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  380. Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed
  381. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  382. Hu Y, et al. 2021. Bioact Mater. 2905:6. PubMed
  383. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  384. Hsu CY, et al. 2020. Frontiers in Immunology. 11:574839. PubMed
  385. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  386. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  387. Du Q et al. 2019. Dev Cell. 49(4):618-631 . PubMed
  388. Branchett WJ, et al. 2020. Wellcome Open Research. 0.278472222. PubMed
  389. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  390. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  391. Mittal A, et al. 2021. Sci Rep. 11:10731. PubMed
  392. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  393. Liu Z, et al. 2015. Development. 142: 2452 - 2463. PubMed
  394. Wang Y, et al. 2020. Cell Death Dis. 1.169444444. PubMed
  395. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  396. Shao M, et al. 2021. Cell Stem Cell. 28(4):685-701.e7. PubMed
  397. Timblin GA, et al. 2021. Nat Metab. 3:618. PubMed
  398. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  399. Lang V, et al. 2021. Elife. 10:. PubMed
  400. Toth K, et al. 2022. PLoS Biol. 20:e3001526. PubMed
  401. Weinstock A, et al. 2021. Elife. :10. PubMed
  402. Joffin N, et al. 2021. Cell Stem Cell. 28(4):702-717.e8. PubMed
  403. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  404. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  405. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  406. Sun L, et al. 2015. Sci Rep. 5: 14871. PubMed
  407. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  408. Li CJ, et al. 2018. J Clin Invest. 128:5251. PubMed
  409. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  410. Tuong ZK, et al. 2021. iScience. 24:103326. PubMed
  411. Thomas K, et al. 2022. JCI Insight. :. PubMed
  412. Xu X, et al. 2022. EMBO Rep. 23:e53509. PubMed
  413. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  414. Chandra J, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.83. PubMed
  415. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  416. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  417. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  418. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  419. Ngamsri KC, et al. 2020. Front Immunol. 11:407. PubMed
  420. Haider N, et al. 2020. Cell Commun Signal. 18:26. PubMed
  421. Bernstock JD, et al. 2019. J Allergy Clin Immunol. 145:358. PubMed
  422. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  423. Calle P, et al. 2021. Cells. 10:. PubMed
  424. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  425. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  426. Dong X, et al. 2022. Front Immunol. 13:896472. PubMed
  427. Pizzurro GA, et al. 2021. Cancers (Basel). 13:. PubMed
  428. Olson B, et al. 2021. Brain Behav Immun. 97:102. PubMed
  429. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  430. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  431. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  432. Klose A, et al. 2018. JCSM Rapid Commun. 9:20222. PubMed
  433. Casanova-Acebes M, et al. 2018. J Exp Med. 215:2778. PubMed
  434. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  435. Scott NA, et al. 2018. Front Immunol. 2.319444444. PubMed
  436. Karolin A, et al. 2022. Front Pharmacol. 12:789080. PubMed
  437. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  438. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  439. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
  440. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  441. Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed
  442. Ko HJ, et al. 2020. Front Immunol. 1897:11. PubMed
  443. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  444. Böhm AM et al. 2019. Dev Cell. 51(2):236-254 . PubMed
  445. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  446. Mello AM, et al. 2022. Oncogenesis. 11:56. PubMed
  447. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  448. Sánchez-del-Campo L, et al. 2021. J Exp Clin Cancer Res. 40:117. PubMed
  449. Steele NG, et al. 2021. Clin Cancer Res. 27:2023. PubMed
  450. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  451. Mesnieres M, et al. 2021. Cell Reports. 36(8):109618. PubMed
  452. Doss PMIA, et al. 2021. Cell Reports. 34(10):108833. PubMed
  453. Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed
  454. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  455. Baron CS, et al. 2018. Nat Commun. 9:2517. PubMed
  456. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  457. Miragaia RJ, et al. 2018. Sci Rep. 8:685. PubMed
  458. Yu H, et al. 2021. Cell Death Dis. 13:1. PubMed
  459. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  460. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  461. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  462. Patel K, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.11. PubMed
  463. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  464. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  465. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  466. Chung S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. L921:318. PubMed
  467. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  468. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  469. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  470. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  471. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  472. Schulze J, et al. 2021. Stroke. 52:2939. PubMed
  473. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  474. Liu SS, et al. 2021. Immunity. :. PubMed
  475. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  476. Gao P, et al. 2020. Front Immunol. 1.636111111. PubMed
  477. Durga Devi T, et al. 2017. Am J Pathol. 187:2659. PubMed
  478. Wang L, et al. 2020. Nat Commun. 0.654166667. PubMed
  479. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  480. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  481. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  482. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  483. Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed
  484. Garcia-Alegria E, et al. 2016. Sci Rep. 6: 25917. PubMed
  485. Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed
  486. Mitchell LA, et al. 2019. Oncotarget. 10:2252. PubMed
  487. Han Y, et al. 2019. J Clin Invest. 130:26. PubMed
  488. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  489. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  490. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  491. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  492. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
  493. Sheriff L, et al. 2020. Dis Model Mech. 13:dmm046383. PubMed
  494. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
  495. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  496. Omori S, et al. 2020. Cell Metabolism. 32(5):814-828.e6. PubMed
  497. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  498. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
RRID
AB_893344 (BioLegend Cat. No. 103131)
AB_893340 (BioLegend Cat. No. 103132)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

How stable is PerCP/Cyanine5.5 tandem as compared to PerCP alone?

PerCP/Cyanine5.5 is quite photostable and also better than PerCP alone in withstanding fixation.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Spark YG™ 581 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS V475™ anti-mouse CD45 Antibody 30-F11 FC
StarBright UltraViolet 740 anti-mouse CD45 30-F11 FC
Go To Top Version: 3    Revision Date: 08/24/2018

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account